Literature DB >> 8763845

Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex.

R F Anderson1, W A Denny, D C Ware, W R Wilson.   

Abstract

The kinetic basis for the in vitro hypoxia-selective cytotoxicity (HSC) of the Co(III)-nitrogen mustard complex SN 24771 (NSC 675352) has been investigated using pulse radiolysis. The rate constants for the one-electron reduction of SN 24771 by model reductants exhibited a marked dependence on the one-electron reduction potential of the reductant, with values up to several orders of magnitude slower than for the nitroimidazole drug misonidazole. Following one-electron reduction to form the Co(II) complex (species I) consecutive conversion to further transient species (II and III) occurs with first order rate constants of 120 +/- 10 s-1 and 10 +/- 2 s-1 and are associated with release of ligands. Neither of these subsequent processes are inhibited by the addition of O2 up to a concentration of 0.5 mmol l-1 suggesting that the HSC action of SN 24771 most likely arises from a mechanism other than simple redox cycling between the Co(III) and Co(II) forms by O2. If the measured low rate constants of one-electron reduction by model reductants of SN 24771 (as compared to the reduction of nitroaromatics), is mirrored by biological reductants, then it is proposed that HSC may occur through competition between SN 24771 and O2 for these reductants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763845      PMCID: PMC2149997     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  5 in total

1.  Correlation of kinetic parameters of nitroreductase enzymes with redox properties of nitroaromatic compounds.

Authors:  M V Orna; R P Mason
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

2.  Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.

Authors:  W R Wilson; J W Moselen; S Cliffe; W A Denny; D C Ware
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-05-15       Impact factor: 7.038

Review 3.  Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).

Authors:  W A Denny; W R Wilson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

4.  Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.

Authors:  B G Siim; W R Wilson
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

5.  Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.

Authors:  D C Ware; B D Palmer; W R Wilson; W A Denny
Journal:  J Med Chem       Date:  1993-06-25       Impact factor: 7.446

  5 in total
  8 in total

Review 1.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

Review 2.  Recent developments in the design of bioreductive drugs.

Authors:  W A Denny; W R Wilson; M P Hay
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Synthesis, characterization, and antibacterial and anticancer screening of {M(2+)-Co (3+)-M (2+)} and {Co (3+)-M (2+)} (M is Zn, Cd, Hg) heterometallic complexes.

Authors:  Nagendra K Kaushik; Anurag Mishra; Afsar Ali; J S Adhikari; Akhilesh K Verma; Rajeev Gupta
Journal:  J Biol Inorg Chem       Date:  2012-09-23       Impact factor: 3.358

4.  Cellular uptake and distribution of cobalt complexes of fluorescent ligands.

Authors:  Natsuho Yamamoto; Sarah Danos; Paul D Bonnitcha; Timothy W Failes; Elizabeth J New; Trevor W Hambley
Journal:  J Biol Inorg Chem       Date:  2008-04-17       Impact factor: 3.358

5.  Targeting hypoxia in the leukemia microenvironment.

Authors:  Juliana Benito; Zhihong Zeng; Marina Konopleva; William R Wilson
Journal:  Int J Hematol Oncol       Date:  2013-08-01

Review 6.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

7.  Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.

Authors:  Marlene Mathuber; Hemma Schueffl; Orsolya Dömötör; Claudia Karnthaler; Éva A Enyedy; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Inorg Chem       Date:  2020-11-21       Impact factor: 5.165

8.  Development of a cobalt(iii)-based ponatinib prodrug system.

Authors:  Marlene Mathuber; Michael Gutmann; Mery La Franca; Petra Vician; Anna Laemmerer; Patrick Moser; Bernhard K Keppler; Walter Berger; Christian R Kowol
Journal:  Inorg Chem Front       Date:  2021-03-30       Impact factor: 6.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.